Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

MODURETIC 5-50

AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Standard Dose
EQ 5MG ANHYDROUS;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview MODURETIC 5-50 is listed in Drugs@FDA under application 018201 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - EQ 5MG ANHYDROUS;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 2003-02-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview MODURETIC 5-50 is listed in Drugs@FDA under application 018201 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - EQ 5MG ANHYDROUS;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 2003-02-25 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
MODURETIC 5-50 (AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE) | Drug Monograph | MedicHelpline